Literature DB >> 27593586

Current best practice and controversies in the follow up of patients with asymptomatic branch duct IPMN of the pancreas.

Masao Tanaka1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27593586      PMCID： PMC5011155          DOI： 10.1016/j.hpb.2016.06.014

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  15 in total

Review 1.  International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.

Authors:  Masao Tanaka; Suresh Chari; Volkan Adsay; Carlos Fernandez-del Castillo; Massimo Falconi; Michio Shimizu; Koji Yamaguchi; Kenji Yamao; Seiki Matsuno
Journal:  Pancreatology       Date:  2006       Impact factor: 3.996

2.  American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.

Authors:  Santhi Swaroop Vege; Barry Ziring; Rajeev Jain; Paul Moayyedi
Journal:  Gastroenterology       Date:  2015-04       Impact factor: 22.682

Review 3.  Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.

Authors:  Brian K P Goh; Zhimin Lin; Damien M Y Tan; Choon-Hua Thng; Christopher J L Khor; Tony K H Lim; London L P J Ooi; Alexander Y F Chung
Journal:  Surgery       Date:  2015-05-29       Impact factor: 3.982

Review 4.  Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis.

Authors:  Stefano Crippa; Gabriele Capurso; Calogero Cammà; Gianfranco Delle Fave; Carlos Fernández-Del Castillo; Massimo Falconi
Journal:  Dig Liver Dis       Date:  2016-02-18       Impact factor: 4.088

5.  An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Takao Ohtsuka; Hiroshi Kono; Yosuke Nagayoshi; Yasuhisa Mori; Kosuke Tsutsumi; Yoshihiko Sadakari; Shunichi Takahata; Katsuya Morimatsu; Shinichi Aishima; Hisato Igarashi; Tetsuhide Ito; Kousei Ishigami; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Surgery       Date:  2011-08-27       Impact factor: 3.982

Review 6.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

7.  Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.

Authors:  Takao Ohtsuka; Hiroshi Kono; Reiko Tanabe; Yosuke Nagayoshi; Yasuhisa Mori; Yoshihiko Sadakari; Shunichi Takahata; Yasunori Oda; Shinichi Aishima; Hisato Igarashi; Tetsuhide Ito; Kousei Ishigami; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Am J Surg       Date:  2011-10-13       Impact factor: 2.565

8.  Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.

Authors:  Ken Kamata; Masayuki Kitano; Masatoshi Kudo; Hiroki Sakamoto; Kumpei Kadosaka; Takeshi Miyata; Hajime Imai; Kiyoshi Maekawa; Takaaki Chikugo; Masashi Kumano; Tomoko Hyodo; Takamichi Murakami; Yasutaka Chiba; Yoshifumi Takeyama
Journal:  Endoscopy       Date:  2013-11-11       Impact factor: 10.093

9.  Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Authors:  Noboru Ideno; Takao Ohtsuka; Hiroshi Kono; Kenji Fujiwara; Yasunori Oda; Shinichi Aishima; Tetsuhide Ito; Kousei Ishigami; Shoji Tokunaga; Kenoki Ohuchida; Shunichi Takahata; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

10.  "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Teppei Aso; Takao Ohtsuka; Taketo Matsunaga; Hideyo Kimura; Yusuke Watanabe; Koji Tamura; Noboru Ideno; Takashi Osoegawa; Shunnichi Takahata; Koji Shindo; Yasuhiro Ushijima; Shinichi Aishima; Yoshinao Oda; Tetsuhide Ito; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327
View more
  3 in total

1.  Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alan R Penheiter; Dinesh K Deelchand; Emily Kittelson; Sibel Erdogan Damgard; Stephen J Murphy; Daniel R O'Brien; William R Bamlet; Marie R Passow; Thomas C Smyrk; Fergus J Couch; George Vasmatzis; John D Port; Małgorzata Marjańska; Stephanie K Carlson
Journal:  Pancreatology       Date:  2017-11-14       Impact factor: 3.996

2.  Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons.

Authors:  Hans G Beger
Journal:  J Gastrointest Surg       Date:  2018-01-03       Impact factor: 3.452

3.  Resection of benign side-branch intraductal papillary mucinous neoplasm of the pancreas-is long term follow-up indicated?: A case report and review of the literature.

Authors:  Stefan Fritz; Regina Küper-Steffen; Katharina Feilhauer; Christoph M Sommer; Götz M Richter; René Hennig; Jörg Köninger
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.